Open research questions in Pituitary Gland Disorders and Treatments
160 gap statements mined from Pituitary Gland Disorders and Treatments papers in our 4.5M-paper local library, which holds 712 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.
Choosing where to publish on Pituitary Gland Disorders and Treatments? See the ranked Medicine journals.
What the literature leaves open
The clinicopathological features of collision tumors involving PitNETs and other sellar neoplasms remain incompletely characterized. The occurrence of pituicytomas associated with pituitary hyperfunction is significantly limited.
Case Report: Rare collision tumors: ACTH-secreting pituitary neuroendocrine tumor and pituicytoma – histopathological and ultrastructural analysis · 2026 · DOIPersonalized therapeutic strategies for collision tumors of the sellar region have not been established. Future studies should investigate whether tumors with combined ACTH-secreting PitNET and pituicytoma components exhibit different treatment responses to pharmacological therapy (dopamine agonists, somatostatin analogs) or require modified surgical approaches compared to conventional pituitary adenomas.
Case Report: Rare collision tumors: ACTH-secreting pituitary neuroendocrine tumor and pituicytoma – histopathological and ultrastructural analysis · 2026 · DOIFuture studies can apply the developed ontology to other surgical procedures. The use of AI-driven surgical video analysis can be explored further. The study's findings can inform the development of more effective surgical training and education programs.
Action classification for endoscopic pituitary adenoma resection: a consensus-based study · 2026 · DOIThe association between technique and outcomes in pituitary adenoma resection remains poorly defined. Existing workflow analyses focus on broad procedural steps and phases, lacking a detailed, action-level approach.
Action classification for endoscopic pituitary adenoma resection: a consensus-based study · 2026 · DOIThere is a lack of understanding of the relationship between preoperative radiological compression features and pre- and postoperative visual field defects. There is a need for a novel method for predicting the outcome of visual field defects.
Preoperative radiological compression features and their relationship with pre- and postoperative visual field defects in pituitary macroadenomas: a retrospective cohort from the neuro-ophthalmological clinic · 2026 · DOIFurther studies are needed to elucidate the mechanisms by which RGS4 promotes tumor cell proliferation and inhibits apoptosis. The development of targeted therapies for SF-1 lineage PitNETs based on RGS4 expression may be a promising area of research. Investigation of the clinical utility of RGS4 as a biomarker for predicting tumor behavior and treatment response is warranted.
Integrating single-cell and bulk RNA sequencing data reveals RGS4 as a functional driver in a proliferative subgroup of SF-1 lineage PitNETs · 2026 · DOILimited understanding of the relationship between prognostic nutritional index and inflammatory indices as predictors of perioperative infection in patients with Cushing syndrome.
Prognostic nutritional index and inflammatory indices as predictors of perioperative infection in patients with Cushing syndrome: a retrospective single-center study · 2026 · DOIFourth, although fibrous bodies are an important morphologic feature in parts of the PIT-1 lineage spectrum, they were not specifically annotated or quantified in this study, and their contribution to model prediction remains uncertain.
Lineage Classification of Pituitary Neuroendocrine Tumors From Whole-Slide Images Using Attention-Guided Graph Representation Learning · 2026 · DOIThe absence of universally accepted diagnostic criteria for cyclical Cushing's syndrome is a significant gap. The need for longitudinal biochemical surveillance and advanced localization strategies is not well established.
Cyclical ectopic Cushing’s syndrome due to a mediastinal neuroendocrine tumor: a case-based review · 2026 · DOIThe median follow-up of 16 months, with a minimum of 4 months in a subset of patients, is insufficient to fully characterize long-term recurrence patterns, and conclusions should be considered preliminary given that recurrence rates of up to 50% at 10 years have been reported.
Clinicopathological features and outcomes of immature PIT-1 lineage tumors: A high-risk pituitary neuroendocrine tumor/pituitary adenoma subtype per WHO 2022 · 2026 · DOIThe study is limited by its retrospective design. The sample size is relatively small. The heterogeneity of patient follow-up intervals may introduce variability. The inclusion period spans advances in radiosurgery planning, which might introduce variability in dosimetry.
LINAC Stereotactic Radiosurgery for Functional Pituitary Adenomas Following Recurrence After Transsphenoidal Surgery: Tumor Control and Endocrine Outcomes in a Single-center Series · 2026 · DOIFurther studies are needed to fully understand the effects of LINAC SRS on functional pituitary adenomas. The study's results can inform the development of more effective treatment strategies for patients with functional pituitary adenomas. Long-term follow-up studies are needed to assess the durability of tumor control and endocrine outcomes.
LINAC Stereotactic Radiosurgery for Functional Pituitary Adenomas Following Recurrence After Transsphenoidal Surgery: Tumor Control and Endocrine Outcomes in a Single-center Series · 2026 · DOIThe coexistence of exogenous and endogenous Cushing's syndrome is very rare and may lead to delayed diagnosis and management. There are no data on the incidence of exogenous Cushing's syndrome.
The study has a limited sample size, which may have contributed to the lack of statistical significance in the differences between the cabergoline and control groups. The study relies on self-report questionnaires and semi-structured interviews, which may be subject to biases and limitations.
Impulse control disorders and their relationship with psychopathology in patients treated with cabergoline for hyperprolactinaemia · 2026 · DOIThere is a lack of studies evaluating the efficacy of postoperative screening for distress symptom cluster in patients undergoing surgery for PA.
Postoperative screening for distress symptom cluster in patients with pituitary adenomas: a propensity-score matched outcome analysis · 2026 · DOIThe study notes that publication bias was not formally assessed with funnel plots due to the small number and heterogeneity of included studies. The study also notes that the lack of prospective studies limits the interpretability of the results.
Pituitary adenoma and intracerebral aneurysms: case series, systematic review and meta-analysis · 2026 · DOIFuture studies should investigate the underlying mechanisms of the association between IAs and PAs. Future studies should explore the clinical implications of the study's findings. Future studies should aim to develop clinical guidelines for the management of PA patients with IAs.
Pituitary adenoma and intracerebral aneurysms: case series, systematic review and meta-analysis · 2026 · DOIPrior work has not fully defined the predictors of durable surgical remission. There is a need to identify clinical, radiographic, and biochemical factors associated with remission and recurrence.
Determinants of remission and recurrence following transsphenoidal surgery for prolactinoma: a single-center experience · 2026 · DOITherefore, the generalizability of the model across different institutions remains to be established.
Multi-sequence pituitary tumor MRI–based deep learning model for predicting aggressive acromegaly · 2026 · DOIThe progression from non-alcoholic fatty liver disease to end-stage liver cirrhosis in patients with panhypopituitarism is exceptionally rare and seldom reported. The association between hypopituitarism and non-alcoholic fatty liver disease is established, but the underlying mechanisms are not fully understood.
Decompensated liver cirrhosis as a rare consequence of long-term untreated panhypopituitarism after craniopharyngioma resection: a case report · 2026 · DOIAs the molecular identity of fluorophore(s) underlying pituitary NIRAF in endocrine organs remains unknown, our interpretation is intentionally restricted to microstructural determinants resolved by confocal spectral imaging.
NIR autofluorescence allows for pituitary gland detection during surgery: evidence from microscopic studies and in vivo measurements · 2026 · DOIAlthough BRAF V600E has been detected in plasma and CSF in isolated reports, the evidence remains sparse, and current assays may lack the sensitivity required to reliably detect CP driver mutations.
Despite these observations, a major limitation in the field is the lack of standardized treatment protocols and prognostic models due to the rarity of pituitary metastases. However, this observation is likely influenced by selection and indication bias, and the extent of resection itself has not been established as an independent determinant of survival.
Pituitary metastasis revisited: a retrospective single-center experience with diagnostic challenges and surgical nuances. Illustrative cases · 2026 · DOIThe locally infiltrative growth pattern of craniopharyngiomas, which can mimic aggressive biological behavior. The risk of brain retraction and limited inferior midline visualization associated with traditional transcranial approaches.
The Evolving Role of the Endoscopic Endonasal Transplanum–Transtuberculum Approach in the Management of Craniopharyngiomas: A Systematic Review of Outcomes, Reconstruction, and Surgical Evolution · 2026 · DOITrial registration numberChiCTR2400081636 STRENGTHS AND LIMITATIONS OF THIS STUDYO_ST_ABSStrengthC_ST_ABS[tpltrtarr] This study proposes an integrated, clinically applicable preoperative strategy that combines imaging-based prediction with selective cerebrospinal fluid cell-free DNA analysis to identify papillary craniopharyngioma (PCP) prior to surgery.
Study protocol for preoperative classification using integrated screening and short-course neoadjuvant BRAF/MEK inhibition in newly diagnosed papillary craniopharyngioma (the PRECISE-PCP study): a prospective single-arm study · 2026 · DOI
Most-cited papers in Pituitary Gland Disorders and Treatments
- Diagnosis and Treatment of Pituitary Adenomas · JAMA · 2017 · 905 citations
- Consensus on diagnosis and management of Cushing's disease: a guideline update · The Lancet Diabetes & Endocrinology · 2021 · 901 citations
- Overview of the 2022 WHO Classification of Pituitary Tumors · Endocrine Pathology · 2022 · 571 citations
- Growth and endocrine sequelae of craniopharyngioma. · Archives of Disease in Childhood · 1996 · 172 citations
- Metyrapone in long-term management of Cushing's disease. · BMJ · 1977 · 127 citations
- Clinical Correlates of Major Depression in Cushing’s Disease · Psychopathology · 1998 · 115 citations
- Antipsychotic-Induced Hyperprolactinaemia · Australian & New Zealand Journal of Psychiatry · 2011 · 108 citations
- Pituitary Adenomas in Old Age · Journal of Gerontology · 1980 · 96 citations
- Stereotactic radiotherapy and radiosurgery for non-functioning and secreting pituitary adenomas · Reports of Practical Oncology & Radiotherapy · 2014 · 83 citations
- Pituitary Apoplexy in Five Patients with Pituitary Tumours · BMJ · 1971 · 70 citations
Most recent work
- Risk of recurrence after successful surgery for Cushing's disease and association with USP8 genotype and tumour size: an international, retrospective, longitudinal cohort study · The Lancet Diabetes & Endocrinology · 2026
- Efficacy and safety of relacorilant for the treatment of patients with Cushing's syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study · The Lancet Diabetes & Endocrinology · 2026
- Single-cell transcriptomics reveals the landscape of immune phenotypes in pituitary neuroendocrine tumors · Chinese Medical Journal · 2026
- Acromegaly complications: an update · The Journal of Clinical Endocrinology & Metabolism · 2026
- The value of targeting CXCR4 with 68Ga-Pentixafor PET/MRI for Cushing’s disease: a retrospective cohort study · European Journal of Nuclear Medicine and Molecular Imaging · 2026
- Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement · The Journal of Clinical Endocrinology & Metabolism · 2026
- Distinct plasma protein profiles after long-term remission of Cushing's disease · The Journal of Clinical Endocrinology & Metabolism · 2026
- Genomic characterization of aggressiveness in pituitary neuroendocrine tumors · Neuro-Oncology · 2026
- Acromegaly is associated with an increased incidence of primary malignant tumors: data from a national study in Sweden · The Journal of Clinical Endocrinology & Metabolism · 2026
- The germline landscape of pituitary adenomas: established and emerging predisposition genes · The Journal of Clinical Endocrinology & Metabolism · 2026
Find a gap in your own Pituitary Gland Disorders and Treatments sub-topic
This page shows what the Pituitary Gland Disorders and Treatments literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 4.5M-paper local library and writes the gaps from its rows.
Open the Research Gap Finder →